Skip to main content
Premium Trial:

Request an Annual Quote

Telechem, BioSystems International to Collaborate on Proteome Microarray

NEW YORK (GenomeWeb News) – Integrated Media Holdings today said that its wholly owned subsidiary, Telechem International, has entered into an exclusive agreement with BioSystems International to make and sell microarrays featuring antibodies that identify proteins uniquely expressed in human plasma.
 
Under the pact, BSI will provide normal human plasma-profiling monoclonal antibodies. Telechem, which also operates under the name Arrayit, will use its microarray technology to print the antibodies onto glass slides. It also will market the Human Plasma Proteome Microarray through its existing network of worldwide marketing partners.
 
“This unique approach of using novel antibodies to detect human plasma proteins will speed the research and identification of biomarkers for early-stage disease diagnostics,” Telechem CEO Rene Schena said in a statement.
 
The partners expect the first microarrays from the collaboration to be available next quarter.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.